Merck’s STRIDE-8 phase 3 trial of Capvaxive demonstrates positive immune responses in adults with increased risk for pneumococcal disease: Rahway, New Jersey Thursday, October 1 ...
US FDA accepts for priority review GSK’s NDA for gepotidacin to treat uncomplicated urinary tract infections in female adults and adolescents: London, UK Thursday, October 17, 2 ...
It has, in fact, been a pretty simple formula for the Bucs in recent seasons when it comes to utilizing the running game. When they have 20 carries or fewer, they are 2-15. When they have 21 carries ...